Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$50.28 - $64.61 $3,720 - $4,781
74 Added 9.57%
847 $49,000
Q1 2022

Mar 30, 2023

SELL
$26.91 - $47.15 $57,237 - $100,288
-2,127 Reduced 73.34%
773 $21,000
Q1 2022

May 12, 2022

SELL
$26.91 - $47.15 $57,237 - $100,288
-2,127 Reduced 73.34%
773 $22,000
Q4 2021

Jun 21, 2023

BUY
$32.97 - $56.85 $70,127 - $120,919
2,127 Added 275.16%
2,900 $133,000
Q3 2021

Jun 21, 2023

BUY
$26.48 - $35.99 $56,322 - $76,550
2,127 Added 275.16%
2,900 $95,000
Q3 2021

Mar 30, 2023

BUY
$26.48 - $35.99 $4,157 - $5,650
157 Added 5.72%
2,900 $95,000
Q3 2021

Nov 15, 2021

BUY
$26.48 - $35.99 $76,792 - $104,371
2,900 New
2,900 $95,000
Q1 2021

May 14, 2021

SELL
$28.4 - $36.14 $77,901 - $99,132
-2,743 Closed
0 $0
Q4 2020

Jun 22, 2023

BUY
$23.69 - $31.47 $46,669 - $61,995
1,970 Added 254.85%
2,743 $79,000
Q3 2020

Jun 26, 2023

BUY
$26.38 - $33.1 $51,968 - $65,207
1,970 Added 254.85%
2,743 $77,000
Q2 2020

Jun 26, 2023

BUY
$29.93 - $50.1 $58,962 - $98,697
1,970 Added 254.85%
2,743 $88,000
Q1 2020

Jul 12, 2023

BUY
$30.35 - $67.14 $59,789 - $132,265
1,970 Added 254.85%
2,743 $111,000
Q1 2020

Mar 30, 2023

SELL
$30.35 - $67.14 $24,583 - $54,383
-810 Reduced 22.8%
2,743 $111,000
Q1 2020

May 15, 2020

SELL
$30.35 - $67.14 $24,583 - $54,383
-810 Reduced 22.8%
2,743 $112,000
Q4 2019

Jul 12, 2023

BUY
$55.65 - $79.83 $154,707 - $221,927
2,780 Added 359.64%
3,553 $219,000
Q3 2019

Jul 12, 2023

BUY
$64.7 - $85.39 $179,866 - $237,384
2,780 Added 359.64%
3,553 $258,000
Q3 2019

Mar 30, 2023

BUY
$64.7 - $85.39 $44,060 - $58,150
681 Added 23.71%
3,553 $258,000
Q3 2019

Nov 14, 2019

BUY
$64.7 - $85.39 $44,060 - $58,150
681 Added 23.71%
3,553 $259,000
Q2 2019

Jul 12, 2023

BUY
$67.77 - $82.2 $142,249 - $172,537
2,099 Added 271.54%
2,872 $236,000
Q1 2019

Jul 13, 2023

BUY
$45.83 - $70.54 $96,197 - $148,063
2,099 Added 271.54%
2,872 $202,000
Q1 2019

Mar 30, 2023

BUY
$45.83 - $70.54 $96,197 - $148,063
2,099 Added 271.54%
2,872 $202,000
Q1 2019

May 16, 2019

SELL
$45.83 - $70.54 $466,045 - $717,321
-10,169 Reduced 77.98%
2,872 $202,000
Q1 2019

May 15, 2019

BUY
$45.83 - $70.54 $466,045 - $717,321
10,169 Added 354.07%
13,041 $108,000
Q4 2018

Jul 13, 2023

BUY
$41.17 - $56.44 $86,415 - $118,467
2,099 Added 271.54%
2,872 $129,000
Q4 2018

Feb 14, 2019

BUY
$41.17 - $56.44 $90,368 - $123,885
2,195 Added 324.22%
2,872 $129,000
Q3 2018

Jul 13, 2023

BUY
$52.95 - $71.34 $111,142 - $149,742
2,099 Added 271.54%
2,872 $162 Million
Q3 2018

Nov 14, 2018

SELL
$52.95 - $71.34 $116,225 - $156,591
-2,195 Reduced 76.43%
677 $38,000
Q4 2017

Feb 15, 2018

SELL
$53.3 - $74.56 $155,209 - $217,118
-2,912 Reduced 50.35%
2,872 $185,000
Q2 2017

Aug 14, 2017

BUY
N/A
5,784
5,784 $271,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $986M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.